0

    524444

    EVEXIA

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    EVEXIA LIFECARE LIMITED Share Price Today

    Investment Returns

    Over 1 Month -12.36% Over 3 Months 207.54% Over 6 Months -1.21% Over 1 Year -36.82%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    EVEXIA LIFECARE LIMITED fundamentals


    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield [-]%
    • Net profit/quarter (Cr) [-]
    info icon alternate text
    • Market cap (Cr) 313.50
    • P/E Ratio (TTM) 163.00
    • Beta 0.28
    • Book Value / share 2.16
    • Return on equity 0.28%
    • EPS (TTM) 0.01
    • Dividend yield [-]%
    • Net profit/quarter (Cr) 0.47
    info icon alternate text

    EVEXIA LIFECARE LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 25.18
    Operating Expense 25.16
    Net Profit 0.47
    Net Profit Margin (%) 1.86
    Earnings Per Share (EPS) 0.00
    EBITDA 0.87
    Effective Tax Rate (%) 17.54
    Particulars DEC 2025 (Values in Cr)
    Revenue 24.60
    Operating Expense 24.31
    Net Profit 0.41
    Net Profit Margin (%) 1.66
    Earnings Per Share (EPS) 0.00
    EBITDA 0.67
    Effective Tax Rate (%) 25.45
    Particulars SEP 2025 (Values in Cr)
    Revenue 25.03
    Operating Expense 24.94
    Net Profit 0.32
    Net Profit Margin (%) 1.27
    Earnings Per Share (EPS) 0.00
    EBITDA 0.55
    Effective Tax Rate (%) 25.58
    Particulars JUN 2025 (Values in Cr)
    Revenue 20.66
    Operating Expense 19.87
    Net Profit 0.59
    Net Profit Margin (%) 2.85
    Earnings Per Share (EPS) 0.00
    EBITDA 0.92
    Effective Tax Rate (%) 26.58
    Particulars MAR 2025 (Values in Cr)
    Revenue 15.18
    Operating Expense 15.56
    Net Profit -0.49
    Net Profit Margin (%) -3.22
    Earnings Per Share (EPS) 0.00
    EBITDA 0.12
    Effective Tax Rate (%) -40.00
    Particulars MAR 2026 (Values in Cr)
    Revenue 105.46
    Operating Expense 104.30
    Net Profit 1.52
    Net Profit Margin (%) 1.44
    Earnings Per Share (EPS) 0.01
    EBITDA 2.73
    Effective Tax Rate (%) 25.72
    Particulars MAR 2025 (Values in Cr)
    Revenue 83.89
    Operating Expense 82.82
    Net Profit 0.73
    Net Profit Margin (%) 0.87
    Earnings Per Share (EPS) 0.01
    EBITDA 2.03
    Effective Tax Rate (%) 40.00
    Particulars MAR 2024 (Values in Cr)
    Revenue 54.90
    Operating Expense 54.24
    Net Profit 1.15
    Net Profit Margin (%) 2.09
    Earnings Per Share (EPS) 0.02
    EBITDA 4.38
    Effective Tax Rate (%) 23.68
    Particulars MAR 2023 (Values in Cr)
    Revenue 68.73
    Operating Expense 67.74
    Net Profit 1.99
    Net Profit Margin (%) 2.89
    Earnings Per Share (EPS) 0.03
    EBITDA 3.42
    Effective Tax Rate (%) 30.17
    Particulars MAR 2022 (Values in Cr)
    Revenue 71.63
    Operating Expense 69.60
    Net Profit 0.80
    Net Profit Margin (%) 1.11
    Earnings Per Share (EPS) 0.03
    EBITDA 2.39
    Effective Tax Rate (%) 61.53
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1.73
    ROE % 1.34
    ROCE % 0.29
    Total Debt to Total Equity 6.76
    EBITDA Margin 5.05
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 1.26
    ROE % 0.85
    ROCE % 0.46
    Total Debt to Total Equity 4.53
    EBITDA Margin 3.54
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 2.37
    ROE % 1.18
    ROCE % 2.48
    Total Debt to Total Equity 0.09
    EBITDA Margin 3.28
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 11.71
    ROE % 1.78
    ROCE % 1.54
    Total Debt to Total Equity 0.10
    EBITDA Margin 2.04
    Particulars MAR 2020 (Values in Cr)
    Book Value / Share 11.51
    ROE % 4.99
    ROCE % 3.08
    Total Debt to Total Equity 0.08
    EBITDA Margin 5.40
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 2.16
    ROE % 0.28
    ROCE % 0.20
    Total Debt to Total Equity 2.01
    EBITDA Margin 2.49
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 1.38
    ROE % 1.26
    ROCE % 0.25
    Total Debt to Total Equity 7.56
    EBITDA Margin 4.41
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 1.27
    ROE % 2.53
    ROCE % 0.68
    Total Debt to Total Equity 4.44
    EBITDA Margin 4.98
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 2.37
    ROE % 1.10
    ROCE % 2.39
    Total Debt to Total Equity 0.08
    EBITDA Margin 3.32
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 11.70
    ROE % 1.74
    ROCE % 1.49
    Total Debt to Total Equity 0.09
    EBITDA Margin 4.16
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.75
    Total Assets 882.99
    Total Liabilities 882.99
    Total Equity 129.36
    Share Outstanding 70
    Price to Book Ratio 1.78
    Return on Assets (%) 0.15
    Return on Capital (%) 0.17
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.47
    Total Assets 847.50
    Total Liabilities 847.50
    Total Equity 90.30
    Share Outstanding 66
    Price to Book Ratio 1.28
    Return on Assets (%) 0.07
    Return on Capital (%) 0.08
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.54
    Total Assets 127.06
    Total Liabilities 127.06
    Total Equity 80.50
    Share Outstanding 30
    Price to Book Ratio 2.43
    Return on Assets (%) 0.67
    Return on Capital (%) 1
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.51
    Total Assets 142.17
    Total Liabilities 142.17
    Total Equity 79.64
    Share Outstanding 6
    Price to Book Ratio 12.54
    Return on Assets (%) 0.90
    Return on Capital (%) 1.48
    Particulars MAR 2020 (Values in Cr)
    Cash & Short Term Investments 0.45
    Total Assets 224.04
    Total Liabilities 224.04
    Total Equity 78.36
    Share Outstanding 6
    Price to Book Ratio 7.23
    Return on Assets (%) 1.54
    Return on Capital (%) 4.06
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 0.02
    Total Assets 864.27
    Total Liabilities 864.27
    Total Equity 434.68
    Share Outstanding 187
    Price to Book Ratio 1.21
    Return on Assets (%) 0.08
    Return on Capital (%) 0.09
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 0.38
    Total Assets 848.22
    Total Liabilities 848.22
    Total Equity 104.90
    Share Outstanding 70
    Price to Book Ratio 1.78
    Return on Assets (%) 0.13
    Return on Capital (%) 0.15
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.07
    Total Assets 835.95
    Total Liabilities 835.95
    Total Equity 91.34
    Share Outstanding 66
    Price to Book Ratio 1.28
    Return on Assets (%) 0.23
    Return on Capital (%) 0.25
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.12
    Total Assets 124.81
    Total Liabilities 124.81
    Total Equity 80.35
    Share Outstanding 30
    Price to Book Ratio 2.43
    Return on Assets (%) 0.64
    Return on Capital (%) 0.93
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.35
    Total Assets 138.73
    Total Liabilities 138.73
    Total Equity 79.52
    Share Outstanding 6
    Price to Book Ratio 12.54
    Return on Assets (%) 0.90
    Return on Capital (%) 1.45
    Particulars MAR 2024 (Values in Cr)
    Net Income 1.92
    Cash from Operations 17.83
    Cash from Investing -17.30
    Cash from Financing 0.56
    Net change in Cash 0.27
    Free Cash Flow 18.09
    Particulars MAR 2023 (Values in Cr)
    Net Income 1.52
    Cash from Operations -1.06
    Cash from Investing -696.61
    Cash from Financing 698.69
    Net change in Cash -1.06
    Free Cash Flow 1.38
    Particulars MAR 2022 (Values in Cr)
    Net Income 2.17
    Cash from Operations -3.65
    Cash from Investing 7.72
    Cash from Financing -0.95
    Net change in Cash 1.02
    Free Cash Flow -1.17
    Particulars MAR 2021 (Values in Cr)
    Net Income 1.92
    Cash from Operations 2.44
    Cash from Investing -2.42
    Cash from Financing 0.77
    Net change in Cash 0.05
    Free Cash Flow 2.63
    Particulars MAR 2020 (Values in Cr)
    Net Income 4.89
    Cash from Operations -3.29
    Cash from Investing 0.53
    Cash from Financing 1.58
    Net change in Cash -0.45
    Free Cash Flow -2.67
    Particulars MAR 2025 (Values in Cr)
    Net Income 1.20
    Cash from Operations -4.83
    Cash from Investing -14.51
    Cash from Financing 20.08
    Net change in Cash -0.35
    Free Cash Flow -4.83
    Particulars MAR 2024 (Values in Cr)
    Net Income 1.51
    Cash from Operations -1.36
    Cash from Investing 2.22
    Cash from Financing 0.27
    Net change in Cash 0.31
    Free Cash Flow -1.10
    Particulars MAR 2023 (Values in Cr)
    Net Income 2.84
    Cash from Operations -1.95
    Cash from Investing -697.41
    Cash from Financing 698.89
    Net change in Cash -1.05
    Free Cash Flow -1.73
    Particulars MAR 2022 (Values in Cr)
    Net Income 2.07
    Cash from Operations -2.79
    Cash from Investing 5.67
    Cash from Financing -0.02
    Net change in Cash 0.77
    Free Cash Flow -0.34
    Particulars MAR 2021 (Values in Cr)
    Net Income 1.85
    Cash from Operations 4.73
    Cash from Investing -4.71
    Cash from Financing 0.88
    Net change in Cash 0.13
    Free Cash Flow 4.91
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ATUL LTD. 6609.45 28.71 3.12 19459.38 5563.00 7793.00
    BASF INDIA LTD 3635.10 37.80 3.97 15734.76 2906.90 5251.00
    ORIENTAL AROMATICS LTD 311.80 318.16 1.57 1049.32 227.05 421.60
    DEEPAK FERTILISERS & PETROCHEM 1543.50 26.43 2.84 19484.81 865.45 1776.95
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    ADVANCE PETROCHEMICALS LTD. 232.00 0.00 5.25 20.88 97.60 320.75
    ATUL LTD. 6609.45 32.70 3.21 19459.38 5563.00 7793.00
    BASF INDIA LTD 3635.10 37.74 3.95 15734.76 2906.90 5251.00
    ORIENTAL AROMATICS LTD 311.80 41.52 1.49 1049.32 227.05 421.60

    EVEXIA LIFECARE LIMITED shareholding pattern

    Holding
    96.41%
    3.36%
    0.12%
    0.09%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    EVEXIA LIFECARE LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    1.67 2.45 redarrow
    red-green-graph indicator
    4 Bearish
    12 Bullish
    • 5 Days 1.60
    • 26 Days 1.60
    • 10 Days 1.70
    • 50 Days 1.50
    • 12 Days 1.70
    • 100 Days 1.40
    • 20 Days 1.60
    • 200 Days 1.60
    1.64 PIVOT
    First Support 1.58 First Resistance 1.70 Second Support 1.52 Second Resistance 1.76 Third Support 1.46 Third Resistance 1.82
    RSI 52.20 ADX 25.82 MACD 0.05 Williams % R -70.37 Commodity Channel Index (CCI) -75.84
    Date 2026-06-29 Week 3802379.00 Same Day 7021298.00 Month 14618279.00
    1 Year 0.28 3 Year 0.68
    Over 1 Month
    -12.36% down
    Over 1 Year
    -36.82% down
    Over 3 Months
    207.54% down
    Over 3 Years
    -12.81% down
    Over 6 Months
    -1.21% down
    Over 5 Years
    -31.82% down

    EVEXIA LIFECARE LIMITED Corporate Actions

    Ex-Date Ex-Bonus Ratio
    26 Oct 2015 23 Oct 2015 1:3
    Ex-Date Old FV NEW FV Record Date
    24 May 2022 2.0 1.0 25 May 2022
    26 Jul 2021 10.0 2.0 27 Jul 2021

    Top Gainers

    Top Losers

    Evexia Lifecare share result highlights

    Evexia Lifecare’s recent financial results reflect steady growth, with improvements in revenue and profitability. The Evexia Lifecare share price responded positively, driven by increased demand for the company’s healthcare and pharmaceutical products. The company’s earnings before interest, taxes, depreciation, and amortisation (EBITDA) also showed growth, indicating strong operational efficiency. Profit margins have improved, supported by effective cost management and increased market presence. Investors are optimistic about the company’s continued expansion and the potential impact on the Evexia Lifecare share price as it strengthens its position in the healthcare sector.
     

    Evexia Lifecare share annual reports

    Evexia Lifecare’s annual reports provide a comprehensive overview of the company’s financial performance over the past year. The company reported consistent revenue growth, which has positively influenced the Evexia Lifecare share price. The balance sheet highlights strong financial management, with a focus on cost efficiency and strategic investments in research and development. The annual reports also detail the company’s plans to expand its product offerings and geographical reach, which are expected to contribute to further growth and positively affect the Evexia Lifecare share price.
     

    Evexia Lifecare share dividend

    Evexia Lifecare has maintained a stable dividend policy, rewarding shareholders with regular payouts. The Evexia Lifecare share price responded favourably to recent dividend announcements, reflecting investor confidence in the company’s financial stability. The dividend payout in the last financial year was aligned with market expectations, ensuring that shareholders receive value while the company retains capital for growth initiatives. Evexia Lifecare’s dividend approach supports its long-term strategy, contributing to the stability and attractiveness of the Evexia Lifecare share price in the market.

    Popular FAQs

    Who is the CEO of Evexia Lifecare?

    The CEO of Evexia Lifecare is responsible for guiding the company’s strategic direction and overseeing its operations. Under their leadership, Evexia Lifecare has expanded its market presence and improved operational efficiency. The CEO’s focus on innovation and growth is instrumental in driving the company’s success and positively impacting the Evexia Lifecare share price. Investors closely monitor the CEO’s leadership to assess the company’s future prospects.
     

    When was Evexia Lifecare established?

    Evexia Lifecare was established several years ago, marking its entry into the healthcare and pharmaceutical sector. Since its inception, the company has grown steadily, contributing to the positive movement of the Evexia Lifecare share price. Over the years, Evexia Lifecare has built a strong reputation in the industry, expanding its product portfolio and market reach. The company’s establishment has laid the foundation for its continued success and growth in the healthcare sector.
     

    What factors influence the Evexia Lifecare share price?

    Several factors influence the Evexia Lifecare share price, including the company’s financial performance, product demand, and operational efficiency. Internal factors such as revenue growth, profit margins, and innovation in product development also play a significant role. Additionally, external factors like regulatory changes, market conditions, and industry trends impact the share price. Investors monitor these variables closely to assess potential movements in the Evexia Lifecare share price and make informed investment decisions.
     

    Is Evexia Lifecare debt free?

    Evexia Lifecare is not entirely debt-free but maintains a manageable level of debt that supports its operational and growth initiatives. The company’s financial reports show that its debt levels are well-controlled and do not pose significant risks to its financial health. This prudent debt management positively influences the Evexia Lifecare share price, as the company continues to focus on growth while maintaining financial stability.
     

    How has the Evexia Lifecare share price performed over the past year?

    The Evexia Lifecare share price has experienced moderate fluctuations over the past year, reflecting the company’s financial performance and broader market conditions. While the share price saw periods of growth driven by strong earnings and market demand, it also faced some volatility due to external factors. Overall, the Evexia Lifecare share price has remained stable, reflecting the company’s solid position in the healthcare sector. Investors continue to monitor the company’s performance for future growth potential.

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Evexia Lifecare Ltd?

    Answer Field

    Evexia Lifecare Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 1.67 as on Jul 01 2026 10:23 AM.

    What is the Market Cap of Evexia Lifecare Ltd Share?

    Answer Field

    The market cap of Evexia Lifecare Ltd for NSE ₹ 0.00 & for BSE ₹ 313.50 as on Jul 01 2026 10:23 AM.

    What is the 52 Week High and Low of Evexia Lifecare Ltd?

    Answer Field

    The 52 Week High and Low of Evexia Lifecare Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 2.69 and ₹ 0.47.

    What is 1 year return for Evexia Lifecare Ltd?

    Answer Field

    The 1 year returns on the stock has been -36.82%.

    What is the P/E Ratio of Evexia Lifecare Ltd Share?

    Answer Field

    As on Jul 01 2026 10:23 AM the price-to-earnings (PE) ratio for Evexia Lifecare Ltd share is 163.00.

    What is the PB ratio of Evexia Lifecare Ltd Share?

    Answer Field

    As on Jul 01 2026 10:23 AM, the price-to-book (PB) ratio for Evexia Lifecare Ltd share is 2.16.

    How to Buy Evexia Lifecare Ltd Share?

    Answer Field

    You can trade in Evexia Lifecare Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Evexia Lifecare Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Evexia Lifecare Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Evexia Lifecare Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    Who is the CEO of Evexia Lifecare?

    Answer Field

    The CEO of Evexia Lifecare is responsible for guiding the company’s strategic direction and overseeing its operations. Under their leadership, Evexia Lifecare has expanded its market presence and improved operational efficiency. The CEO’s focus on innovation and growth is instrumental in driving the company’s success and positively impacting the Evexia Lifecare share price. Investors closely monitor the CEO’s leadership to assess the company’s future prospects.

    When was Evexia Lifecare established?

    Answer Field

    Evexia Lifecare was established several years ago, marking its entry into the healthcare and pharmaceutical sector. Since its inception, the company has grown steadily, contributing to the positive movement of the Evexia Lifecare share price. Over the years, Evexia Lifecare has built a strong reputation in the industry, expanding its product portfolio and market reach. The company’s establishment has laid the foundation for its continued success and growth in the healthcare sector.

    What factors influence the Evexia Lifecare share price?

    Answer Field

    Several factors influence the Evexia Lifecare share price, including the company’s financial performance, product demand, and operational efficiency. Internal factors such as revenue growth, profit margins, and innovation in product development also play a significant role. Additionally, external factors like regulatory changes, market conditions, and industry trends impact the share price. Investors monitor these variables closely to assess potential movements in the Evexia Lifecare share price and make informed investment decisions.

    Is Evexia Lifecare debt free?

    Answer Field

    Evexia Lifecare is not entirely debt-free but maintains a manageable level of debt that supports its operational and growth initiatives. The company’s financial reports show that its debt levels are well-controlled and do not pose significant risks to its financial health. This prudent debt management positively influences the Evexia Lifecare share price, as the company continues to focus on growth while maintaining financial stability.

    How has the Evexia Lifecare share price performed over the past year?

    Answer Field

    The Evexia Lifecare share price has experienced moderate fluctuations over the past year, reflecting the company’s financial performance and broader market conditions. While the share price saw periods of growth driven by strong earnings and market demand, it also faced some volatility due to external factors. Overall, the Evexia Lifecare share price has remained stable, reflecting the company’s solid position in the healthcare sector. Investors continue to monitor the company’s performance for future growth potential.

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |